For the second time this month, there’s promising news from a COVID-19 vaccine candidate: Moderna says its shots provide strong protection, a dash of hope against the grim backdrop of coronavirus surges around the world.
Moderna says its vaccine appears to be 94.5 percent effective, according to preliminary data from the company’s still ongoing study. A week ago, competitor Pfizer Inc. announced its own COVID-19 vaccine appeared similarly effective — news that puts both companies on track to seek permission within weeks for emergency use in the US.
Dr. Stephen Hoge, Moderna’s president, welcomes the “really important milestone” but says having similar results from two different companies is what’s most reassuring.
A subject receives a shot in the first-stage safety study clinical trial of a potential vaccine by Moderna for COVID-19, the disease caused by the new coronavirus, at the Kaiser Permanente Washington Health Research Institute in Seattle, March 16, 2020. (AP/Ted S. Warren, File)
“That should give us all hope that actually a vaccine is going to be able to stop this pandemic and hopefully get us back to our lives,” Hoge says. “It won’t be Moderna alone that solves this problem. It’s going to require many vaccines” to meet the global demand.
Prime Minister Benjamin Netanyahu announced in June that Israel signed a deal with Moderna for a future coronavirus vaccine, without specifying the number of doses that would be supplied or the financial details of the agreement.
Last week Israel also signed a deal with Pfizer for its vaccine.
— with AP
It's not (only) about you.
Supporting The Times of Israel isn’t a transaction for an online service, like subscribing to Netflix. The ToI Community is for people like you who care about a common good: ensuring that balanced, responsible coverage of Israel continues to be available to millions across the world, for free.
Sure, we'll remove all ads from your page and you'll unlock access to some excellent Community-only content. But your support gives you something more profound than that: the pride of joining something that really matters.
Join the Times of Israel Community
Join our Community
Already a member? Sign in to stop seeing this
You're a dedicated reader
We’re really pleased that you’ve read X Times of Israel articles in the past month.
That’s why we started the Times of Israel - to provide discerning readers like you with must-read coverage of Israel and the Jewish world.
So now we have a request. Unlike other news outlets, we haven’t put up a paywall. But as the journalism we do is costly, we invite readers for whom The Times of Israel has become important to help support our work by joining The Times of Israel Community.
For as little as $6 a month you can help support our quality journalism while enjoying The Times of Israel AD-FREE, as well as accessing exclusive content available only to Times of Israel Community members.
Thank you,
David Horovitz, Founding Editor of The Times of Israel
Join Our Community
Join Our Community
Already a member? Sign in to stop seeing this
From the Liveblog of
Monday, November 16, 2020
